Skip to main content
Novonesis AS logo

Novonesis AS — Investor Relations & Filings

Ticker · NSIS ISIN · DK0060336014 LEI · 529900T6WNZXD2R3JW38 CO Manufacturing
Open in API
Filings indexed 2,308 across all filing types
Latest filing 2012-05-11 Director's Dealing
Country DK Denmark
Listing CO NSIS

About Novonesis AS

https://www.novozymes.com/en

Novonesis is a global biosolutions company formed through the combination of Novozymes and Chr. Hansen. The company develops and produces a broad portfolio of biological solutions, including industrial enzymes, functional proteins, and microorganisms such as cultures, probiotics, and yeast. Its products are utilized in over 30 industries to improve efficiency, sustainability, and product quality. Key markets include food and beverage, where solutions enhance nutrition and reduce waste; human and animal health; agriculture, promoting higher crop yields and animal welfare; and household care, for more effective cleaning. Novonesis applies biotechnological principles to address global challenges in production and consumption, aiming to create more sustainable systems and products.

Recent filings

Filing Released Lang Actions
Director's Dealing 2012
Director's Dealing
2012-05-11 Danish
Major Shareholding Notification 2012
Major Shareholding Notification
2012-05-10 Danish
Director's Dealing 2012
Director's Dealing Classification · 98% confidence The document explicitly states that Novozymes is announcing a reduction in the holding of B shares by Baillie Gifford & Co and its subsidiary, detailing the new percentage ownership (7.71% from 7.81%). This type of filing, which reports changes in significant share ownership by an entity, directly corresponds to the definition of Major Shareholding Notification (MRQ). The document is short and focuses solely on this ownership change, not being a full report or a general regulatory announcement.
2012-05-10 English
Legal Proceedings Report 2012
Legal Proceedings Report Classification · 99% confidence The document text is a short announcement dated May 7, 2012, detailing a specific legal event: a judge overturning a jury verdict in a US patent lawsuit involving Novozymes and Danisco regarding patent no. 7.713.723. It includes quotes from management, contact information, and a concluding statement that the ruling does not affect 2012 full-year expectations. This content strongly suggests an official, material announcement made outside of the standard periodic financial reports (like 10-K or IR). Since it concerns a significant legal matter and is presented as a formal company communication (Selskabsmeddelelse nr. 37, 2012), it fits best under the 'Legal Proceedings Report' (LTR) category, which covers updates on significant lawsuits and regulatory actions. It is too specific for a general Regulatory Filing (RNS) and is not a transcript, earnings release, or management discussion.
2012-05-07 English
Legal Proceedings Report 2012
Legal Proceedings Report Classification · 98% confidence The document text explicitly discusses a legal matter: a US patent law suit involving Novozymes and Danisco, a court ruling by Judge Barbara Crabb, the invalidation of a patent, and the vacating of a jury verdict regarding willful infringement and damages. This content directly relates to significant legal proceedings involving the company. Based on the definitions, Legal Proceedings Report (LTR) is the most appropriate classification.
2012-05-07 English
Major Shareholding Notification 2012
Major Shareholding Notification Classification · 99% confidence The document text is very short (508 characters) and written in Danish. It explicitly states that Novozymes has received notification regarding a change in shareholding by Baillie Gifford & Co, increasing their holding to 7.81% of the capital. This describes a change in significant share ownership, crossing a threshold, which directly corresponds to the definition of a Major Shareholding Notification (MRQ). The final sentence 'Læs hele meddelelsen' (Read the full announcement) suggests this is a brief notification, not the full regulatory filing itself, but the content is specific enough to classify it as MRQ rather than the general RPA or RNS fallback.
2012-05-07 Danish

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.